CELC
Price
$106.96
Change
+$1.68 (+1.60%)
Updated
Jan 16 closing price
Capitalization
4.95B
60 days until earnings call
Intraday BUY SELL Signals
LENZ
Price
$18.29
Change
+$0.15 (+0.83%)
Updated
Jan 16 closing price
Capitalization
572.29M
Intraday BUY SELL Signals
Interact to see
Advertisement

CELC vs LENZ

Header iconCELC vs LENZ Comparison
Open Charts CELC vs LENZBanner chart's image
Celcuity
Price$106.96
Change+$1.68 (+1.60%)
Volume$411.3K
Capitalization4.95B
LENZ Therapeutics
Price$18.29
Change+$0.15 (+0.83%)
Volume$1.25M
Capitalization572.29M
CELC vs LENZ Comparison Chart in %
CELC
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CELC vs. LENZ commentary
Jan 18, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a Hold and LENZ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 18, 2026
Stock price -- (CELC: $106.96 vs. LENZ: $18.29)
Brand notoriety: CELC and LENZ are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 47% vs. LENZ: 114%
Market capitalization -- CELC: $4.95B vs. LENZ: $572.29M
CELC [@Biotechnology] is valued at $4.95B. LENZ’s [@Biotechnology] market capitalization is $572.29M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.98B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 1 FA rating(s) are green whileLENZ’s FA Score has 1 green FA rating(s).

  • CELC’s FA Score: 1 green, 4 red.
  • LENZ’s FA Score: 1 green, 4 red.
According to our system of comparison, CELC is a better buy in the long-term than LENZ.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 3 TA indicator(s) are bullish while LENZ’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 3 bullish, 5 bearish.
  • LENZ’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, LENZ is a better buy in the short-term than CELC.

Price Growth

CELC (@Biotechnology) experienced а -0.51% price change this week, while LENZ (@Biotechnology) price change was +23.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.24%. For the same industry, the average monthly price growth was +4.14%, and the average quarterly price growth was +42.40%.

Reported Earning Dates

CELC is expected to report earnings on Mar 19, 2026.

Industries' Descriptions

@Biotechnology (+1.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($4.95B) has a higher market cap than LENZ($572M). LENZ YTD gains are higher at: 14.313 vs. CELC (7.239). LENZ has higher annual earnings (EBITDA): -67.7M vs. CELC (-148.31M). CELC has more cash in the bank: 455M vs. LENZ (202M). LENZ has less debt than CELC: LENZ (954K) vs CELC (320M). LENZ has higher revenues than CELC: LENZ (17.5M) vs CELC (0).
CELCLENZCELC / LENZ
Capitalization4.95B572M865%
EBITDA-148.31M-67.7M219%
Gain YTD7.23914.31351%
P/E RatioN/A48.03-
Revenue017.5M-
Total Cash455M202M225%
Total Debt320M954K33,543%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
PROFIT vs RISK RATING
1..100
7
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCLENZ
RSI
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
86%
Bullish Trend 3 days ago
78%
MACD
ODDS (%)
Bearish Trend 3 days ago
83%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 5 days ago
83%
Declines
ODDS (%)
Bearish Trend 6 days ago
86%
Bearish Trend 10 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
82%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
85%
Bearish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
CELC
Daily Signal:
Gain/Loss:
LENZ
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ESMAX13.390.04
+0.30%
Invesco Global Small Cap Equity A
MAEIX71.03-0.04
-0.06%
MoA Equity Index Fund
CVGCX11.86-0.01
-0.08%
Calamos Growth C
LHCCX21.41-0.10
-0.46%
Lord Abbett Health Care C
FDLSX17.76-0.26
-1.44%
Fidelity Select Leisure

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been closely correlated with IMA. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if CELC jumps, then IMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
+1.60%
IMA - CELC
80%
Closely correlated
-0.76%
NEVPF - CELC
61%
Loosely correlated
N/A
SLXN - CELC
53%
Loosely correlated
-6.97%
ABOS - CELC
44%
Loosely correlated
+1.61%
KYMR - CELC
42%
Loosely correlated
-2.22%
More

LENZ and

Correlation & Price change

A.I.dvisor indicates that over the last year, LENZ has been loosely correlated with BCYC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if LENZ jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LENZ
1D Price
Change %
LENZ100%
+0.83%
BCYC - LENZ
40%
Loosely correlated
+0.62%
BHVN - LENZ
38%
Loosely correlated
+10.23%
MLTX - LENZ
37%
Loosely correlated
+2.51%
CELC - LENZ
36%
Loosely correlated
+1.60%
TARS - LENZ
34%
Loosely correlated
-3.41%
More